Combined Package: Implantable Collamer Lens (ICL)
Implantable Collamer Lens (ICL), also called a phakic IOL, has become a strong alternative for patients with moderate to high myopia, particularly when LASIK/PRK is unsuitable due to thin corneas, high power, or severe dry eyes. The latest EVO/EVO+ ICL, approved by the FDA in 2022, includes a central port that eliminates the need for a pre-operative iridotomy [1].
Who is the ideal candidate?
ICL is most suitable for patients:
– With myopia beyond LASIK/PRK limits.
– With thin or irregular corneas.
– With high astigmatism requiring toric correction.
– Desiring a reversible option, unlike LASIK [2][3].
Safety, Sizing & Long-Term Outcomes
The success of ICL depends on accurate sizing (vault). Modern imaging like AS-OCT and UBM help predict better than traditional white-to-white measurements [4][5]. Long-term studies confirm excellent safety, stable vision, and minimal endothelial loss [6][7]. Cataract remains the main risk, though lower with newer EVO designs [8].
Conclusion
ICL offers an effective, reversible, and safe vision correction option for high myopia and astigmatism when LASIK is not suitable. With proper selection, sizing, and follow-up, outcomes are excellent and patient satisfaction is very high [6][9].
इम्प्लांटेबल कोलामर लेंस (ICL), जिसे फेकिक IOL भी कहा जाता है, मध्यम से अधिक मायोपिया वाले मरीजों के लिए LASIK/PRK का आधुनिक और सुरक्षित विकल्प बन चुका है। नवीनतम EVO/EVO+ ICL में एक केंद्रीय पोर्ट होता है, जिससे प्री-ऑपरेटिव इरिडोटॉमी की आवश्यकता नहीं रहती [1]।
संदर्भ (References – Scientific Sources in English)
[1] FDA Approval EVO/EVO+ Visian ICL (2022)
[2] AAO Preferred Practice Pattern: Refractive Surgery
[3] EyeWiki: Phakic IOLs (ICL)
[4] Reinstein DZ et al. Sulcus-to-sulcus vs WTW sizing studies
[5] Lee SY et al. Angle-to-angle OCT vault prediction
[6] Fernandes P et al. 10-year results with ICL V4c
[7] Guber I et al. Long-term endothelial cell data
[8] Packer M. Complications of phakic IOLs (ASCRS review)
[9] Fernández-Vega et al. Vault and cataract risk in ICL patients
[10] Titiyal JS et al. IPCL vs ICL outcomes in Indian eyes
[11] Sachdev GS et al. Toric phakic lenses in high myopia
About Saluja Eye Care Center, Indore
Established in 2008, Saluja Eye Care Center is a NABH-accredited eye hospital in Indore, trusted for advanced cataract, glaucoma, retina, cornea, refractive and children’s eye care. We are consistently ranked among the top eye hospitals in Madhya Pradesh, delivering superior care with ethical, patient-centered service.
सालुजा आई केयर सेंटर, इंदौर के
बारे में
2008 में स्थापित, सालुजा आई केयर सेंटर इंदौर का NABH मान्यता प्राप्त नेत्र चिकित्सालय है, जहाँ मोतियाबिंद, ग्लूकोमा, रेटिना, कॉर्निया, रिफ्रैक्टिव और बच्चों की आँखों के लिए आधुनिक एवं सुरक्षित उपचार उपलब्ध हैं। मध्यप्रदेश के शीर्ष नेत्र केंद्रों में से एक, हमारा वचन है – नैतिक और मरीज-केंद्रित देखभाल।
Superior Care, Trustworthy Service (श्रेष्ठ चिकित्सा, विश्वसनीय सेवा)
For Appointments/अपॉइंटमेंट के लिए:
Timings: Monday to Saturday, 11 AM – 8 PM (By Prior Appointment)
समय: सोमवार से शनिवार, सुबह 11 से रात 8 बजे (पूर्व अपॉइंटमेंट पर)